What We're Reading
Industry reads hand-picked by our editors
Nov 15, 2019
-
MIT Technology Review
One of CRISPR's inventors has called for controls on gene-editing technology
-
STAT
A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working
-
CNN
FDA issues warning to Dollar Tree about selling 'potentially unsafe drugs'
-
ProPublica
New EPA Rules Aim to Reduce Toxic Emissions. But Many "Cancer Alley" Chemical Plants Won’t Have to Change.
Nov 14, 2019
-
BioCentury
At Trump’s demand, IPI proposal changed to get ‘best deal’ on Part B drugs
-
The New York Times
To drive down insulin prices, W.H.O. will certify generic versions
-
Reuters
Rollout of Johnson & Johnson Ebola vaccine begins in Congo
-
Nature
Founding a global biotechnology summit — while pursuing a PhD
Nov 13, 2019
Nov 12, 2019
Nov 11, 2019
-
Regulatory Focus
Orphan Drug Recall Leaves Patients in the Lurch
-
OneZero
Ambrosia, the Young Blood Transfusion Startup, Is Quietly Back in Business
-
C&EN
C&EN's 2019 10 Start-Ups to Watch
-
The Wall Street Journal
China’s Drug Market Is Opening Up
